Xiushi Biotech's core technical team consists of Ph.D.s, university professors, and industry experts in the fields of synthetic biology, pharmaceuticals, and engineering. The team has led or undertaken over a dozen projects in synthetic biology and recombinant drug industrialization, possessing rich experience in drug development and industrialization.
Recently, Xiu Shi Biopharma ceutical (Nantong) Co., Ltd. (hereinafter referred to as "Xiu Shi Biopharma ceutical") announced that it has completed a multi-million yuan angel round financing, with exclusive investment from Shicui Capital.
